GCC markets · UAE · Regulation

UAE approves 2026-2031 genomics masterplan with personal reports for 900,000 people

Sheikh Khaled bin Mohamed, Crown Prince of Abu Dhabi, approved the UAE's 2026-2031 National Genomics Masterplan, which moves the Emirati Genome Programme towards clinical use and precision medicine, The National reported. Participants will receive personalised genomic reports through the Tamm platform from December 2026.

Illustration of a laboratory sample tube, an open blank report and a DNA double helix beside a sandy Gulf coast.
Illustration. Not a photograph of the event.

The 2026-2031 masterplan was approved at a meeting of the Emirates Genome Council. It moves the national programme from collecting genomic data to using that data in clinical care, early prevention and precision medicine, The National reported. The programme now has one million participants.

The plan has four initiatives. It extends the Emirati Genome Programme to all Emirati citizens and gives personalised genomic reports to 900,000 participants through the Tamm platform from December 2026. It also expands genetic screening of newborns to the whole country and strengthens the Trusted Research Environment for local and international research. Mansoor Al Mansoori, chairman of the Abu Dhabi Department of Health, said the plan sets new criteria for clinical genomics at community level.

Map highlighting UAE

Read the full report

The National — insurance ↗

This is an original summary of the linked report, selected by our GCC market monitor. Facts are attributed to the publication.

More from UAE

All UAE news →

The daily briefing